KemPharm (KMPH) Reports Q2 Loss Per Share of $2.45
Tweet
Share
E-mailGet Alerts KMPH Hot Sheet
Join SI Premium – FREE
KemPharm (NASDAQ: KMPH) reported Q2 EPS of ($2.45), versus ($1.50) reported last year.
For earnings history and earnings-related data on KemPharm (KMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- ClearSign Technologies (CLIR) Tops Q2 EPS by 8c
- Unifi, Inc. (UFI) Misses Q4 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
